The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2025 Annual Report, celebrating continued growth in Membership, record audit sharing, and increased reach in Asia.

Reflecting on the previous year, the 2025 PSCI Annual Report showcases significant milestones in the journey to embed responsible practices in the pharmaceutical value chain.

The PSCI held its first Member Meeting in Shanghai, China, and celebrated 10 years of the India Supplier Conference alongside the delivery of four technical workshops across the sub-continent. These efforts aim to ensure continued progress towards responsible supply chain practices in key sourcing regions for the industry.

The PSCI is powered by 81 Members who represent 70% of the pharma industry and more than $1.2tn revenue collectively. It exists to advance and embed responsible practices in the pharmaceutical, life science, and healthcare supply chains. The PSCI’s Members work together to uphold the PSCI Principles for Responsible Supply Chain Management and collaborate through the association’s strategic focus on Audits, Capability-building, and Projects.